These analyses demonstrated that the association between NAFLD and all‐cause mortality was strongest in nonsmokers, participants with a lower eGFR and participants with a higher NT‐ProBNP. This evidence concerns the gene NPPB and metabolic dysfunction-associated steatotic liver disease.